Company History

The Evolution of Mydecine

Founded in 2020, Mydecine is a biotechnology and digital technology company developing innovative first- and second-generation novel therapeutics for the treatment of mental health and addiction through world-class technology and drug development infrastructure. We are quickly advancing our leadership position through key acquisitions, strategic partnerships, novel drug development, late-stage clinical trials, and cutting-edge technology

This is a timeline of the medical, technology, and business accomplishments of Mydecine Innovation Group.